2.  Min S, Won YK, Kwon S-H, Lim DH. Cost-benefit analysis of a trifocal intraocular lens versus a monofocal intraocular lens in South Korea. Scientific Reports. 2025;15(1):17330.

3.  Kwon S-H, Park JK, Baek HJ, Nam JH, Min S, Cho A-R, et al. Burden of Haemophilia A in South Korea: A Serial Cross-Sectional Study From 2008 to 2021. Haemophilia. 2025;n/a(n/a):687-95.

4.  Tappenden P, Hardiman O, Kwon SH, Mon-Yee M, Galvin M, McDermott C, et al. A Model-Based Economic Evaluation of Hypothetical Treatments for Amyotrophic Lateral Sclerosis in the UK: Implications for Pricing of New and Emerging Health Technologies. Pharmacoeconomics. 2024;42(9):1003-16.

5.  Park H, Yoon EL, Kim M, Kwon SH, Kim D, Cheung R, et al. Cost-effectiveness study of FIB-4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at-risk population. Liver Int. 2024;44(4):944-54.

6.  Min S, Kwon SH, Lee EK, Nam JH. Cost-effectiveness of improving patients' adherence to tuberculosis treatment in South Korea using discrete event simulation. J Infect Public Health. 2024;17(3):478-85.

7.  Lee JE, Nam JH, Kwon SH, Kim BK, Ha SM. Real-world evidence of brigatinib as second-line treatment after crizotinib for ALK+ non-small cell lung cancer using South Korean claims data (K-AREAL). Cancer Med. 2024;13(14):e70030.

8.  Jung HI, Kwon SH, Nam JH, Cho JY, Lee EK. Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2- advanced breast cancer in South Korea, focusing on underrepresented patients. Curr Med Res Opin. 2024(just-accepted):1-9.

9.  Cho JY, Kwon SH, Lee JS, Lee J, Lee JH, Chae Y, et al. Factors associated with COVID-19 vaccination rates in countries with different income levels: a panel analysis. BMC Public Health. 2024;24(1):3538.

10.  Chae Y, Kwon SH, Nam JH, Kang E, Im J, Kim HJ, et al. Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis. Expert Rev Clin Pharmacol. 2024;17(8):721-9.

11.  Park HY, Kwon JW, Kim HL, Kwon SH, Nam JH, Min S, et al. Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens. J Korean Med Sci. 2023;38(21):e167.

12.  Park H, Yoon EL, Kim M, Kwon SH, Jun DW, Kim HL. Letter to the Editor: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional second-tier test? Hepatology. 2023;78(3):E59-E60.

13.  Oh BC, Cho AR, Nam JH, Yang SY, Kim MJ, Kwon SH, et al. Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements. BMC Cancer. 2023;23(1):482.

14.  Na H, Kwon SH, Son KH, Baek Y, Kim J, Lee EK. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis. BioDrugs. 2023;37(2):205-18.

15.  Min S, Kwon SH, Lee YW, Lee JM, Bae EJ, Lee EK. Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea. Vaccines (Basel). 2023;11(5):984.

16.  Lee JE, Kwon SH, Kwon S, Jung HI, Nam JH, Lee EK. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer. JAMA Netw Open. 2023;6(7):e2324852.

17.  Yang SY, Kang DW, Nam JH, Choi EK, Lee EK, Shin JY, et al. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Sci Rep-Uk. 2022;12(1):3413.

18.  Son KH, Kwon SH, Na HJ, Baek Y, Kim I, Lee EK. Quantitative Benefit-Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis. Vaccines (Basel). 2022;10(12):2029.

19.  Oh BC, Lee JE, Nam JH, Hong JY, Kwon SH, Lee EK. Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis. Front Pharmacol. 2022;13:908837.

20.  Kwon SH, Nam JH, Kim HL, Park HY, Kwon JW. Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data. Front Pharmacol. 2022;13:918344.

21.  Jang SC, Oh BC, Nam JH, Lee EK, Kim HL, Kwon SH. Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study. J Heart Lung Transplant. 2022;41(11):1601-10.

22.  Jang SC, Nam JH, Lee SA, An D, Kim HL, Kwon SH, et al. Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis. Orphanet J Rare Dis. 2022;17(1):262.

23.  Jang SC, Kwon SH, Min S, Jo AR, Lee EK, Nam JH. Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System. Front Pharmacol. 2022;13:906211.

24.  Cho JY, Won YK, Park J, Nam JH, Hong JY, Min S, et al. Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery: A Systematic Review and Bayesian Network Meta-analysis. JAMA Ophthalmol. 2022;140(11):1045-53.

25.  Park H, Park CM, Woo JM, Shin JY, Lee EK, Kwon SH. Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants. J Med Econ. 2021;24(1):589-97.

26.  Kwon SH, Park HS, Na YJ, Park C, Shin JY, Kim HL. Price Reduction of Anticancer Drugs from 2007 to 2019 in South Korea: The Impact of Pharmaceutical Cost-Containment Policies. Appl Health Econ Health Policy. 2021;19(3):439-50.

27.  Hong SH, Cho JY, Kim TB, Lee EK, Kwon SH, Shin JY. Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data. J Allergy Clin Immunol Pract. 2021;9(5):1939-47 e7.

28.  Cho JY, Kwon SH, Lee EK, Lee JH, Kim HL. Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data. Front Oncol. 2021;11:728740.

29.  Byun JY, Kim HL, Lee EK, Kwon SH. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. Front Pharmacol. 2021;12:736986.

30.  Yang SY, Park SK, Kang HR, Kim HL, Lee EK, Kwon SH. Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis. BMJ Support Palliat Care. 2020.

31.  Yang SY, Jung HD, Kwon SH, Lee EK, Lee JY, Lee SH. Does Early Retrograde Intrarenal Surgery Improve the Cost-Effectiveness of Renal Stone Management? Yonsei Med J. 2020;61(6):515-23.

32.  Park JA, Lee MY, Nam JH, Shin JY, Wood R, Holbrook T, et al. Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea. Curr Med Res Opin. 2020;36(2):343-51.

33.  Lee YJ, Kwon SH, Hong SH, Nam JH, Song HJ, Lee JS, et al. Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database. Clin Ther. 2017;39(3):527-36.

34.  Kwon SH, Park SK, Byun JH, Lee EK. Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea. Expert Rev Pharmacoecon Outcomes Res. 2017;17(4):411-9.

35.  Byun JH, Kwon SH, Lee JE, Cheon JE, Jang EJ, Lee EK. Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. Patient Prefer Adherence. 2016;10:641-50.

36.  Byun JH, Kwon SH, Ha JH, Lee EK. A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Ther Clin Risk Manag. 2016;12:965-74.

37.  Kim HL, Lee MY, Park SY, Park SK, Byun JH, Kwon S, et al. Comparative effectiveness of cycling of tumor necrosis factor-alpha (TNF-alpha) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-alpha inhibitor using a Bayesian approach. Arch Pharm Res. 2014;37(5):662-70.